These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 26339244)
21. Distribution and prognosis of molecular breast cancer subtypes defined by immunohistochemical biomarkers in a Spanish population-based study. Puig-Vives M; Sánchez MJ; Sánchez-Cantalejo J; Torrella-Ramos A; Martos C; Ardanaz E; Chirlaque MD; Perucha J; Díaz JM; Mateos A; Machón M; Marcos-Gragera R Gynecol Oncol; 2013 Sep; 130(3):609-14. PubMed ID: 23747837 [TBL] [Abstract][Full Text] [Related]
22. Incidence and risk factors for breast cancer subtypes in three distinct South-East Asian ethnic groups: Chinese, Malay and natives of Sarawak, Malaysia. Devi CR; Tang TS; Corbex M Int J Cancer; 2012 Dec; 131(12):2869-77. PubMed ID: 22407763 [TBL] [Abstract][Full Text] [Related]
23. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program. Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999 [TBL] [Abstract][Full Text] [Related]
24. Tumor marker phenotype concordance in second primary breast cancer, California, 1999-2004. Brown M; Bauer K; Pare M Breast Cancer Res Treat; 2010 Feb; 120(1):217-27. PubMed ID: 19629680 [TBL] [Abstract][Full Text] [Related]
25. Pattern of Local Recurrence and Distant Metastasis in Breast Cancer By Molecular Subtype. Wu X; Baig A; Kasymjanova G; Kafi K; Holcroft C; Mekouar H; Carbonneau A; Bahoric B; Sultanem K; Muanza T Cureus; 2016 Dec; 8(12):e924. PubMed ID: 28090417 [TBL] [Abstract][Full Text] [Related]
26. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization. Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228 [TBL] [Abstract][Full Text] [Related]
27. Clinical and Pathological Characteristics of Triple Positive Breast Cancer among Iraqi Patients. Alwan NAS; Mualla FH; Al Naqash M; Kathum S; Tawfiq FN; Nadhir S Gulf J Oncolog; 2017 Sep; 1(25):51-60. PubMed ID: 29019331 [TBL] [Abstract][Full Text] [Related]
28. Breast cancer molecular subtypes in oman: correlation with age, histology, and stage distribution - analysis of 542 cases. Mehdi I; Monem AA; Al Bahrani B; Ramadhan FA Gulf J Oncolog; 2014 Jan; 1(15):38-48. PubMed ID: 24610287 [TBL] [Abstract][Full Text] [Related]
29. Socioeconomic and racial disparities in the selection of chest wall boost radiation therapy in californian women after mastectomy. Hess C; Lee A; Fish K; Daly M; Cress RD; Mayadev J Clin Breast Cancer; 2015 Jun; 15(3):212-8. PubMed ID: 25499694 [TBL] [Abstract][Full Text] [Related]
30. Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery. Pata G; Guaineri A; Bianchi A; Amoroso V; Pasinetti N; Pasini M J Surg Res; 2019 Apr; 236():288-299. PubMed ID: 30694768 [TBL] [Abstract][Full Text] [Related]
31. Socioeconomic status and breast carcinoma survival in four racial/ethnic groups: a population-based study. O'Malley CD; Le GM; Glaser SL; Shema SJ; West DW Cancer; 2003 Mar; 97(5):1303-11. PubMed ID: 12599239 [TBL] [Abstract][Full Text] [Related]
32. [Breast cancer subtypes based on ER/PR and Her2 expression: comparison of MR imaging features]. Hao L; Yu RS; Cui F; Ren XC; Xu HB; Xu KY Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(11):819-23. PubMed ID: 23859386 [TBL] [Abstract][Full Text] [Related]
33. Understanding current racial/ethnic disparities in colorectal cancer screening in the United States: the contribution of socioeconomic status and access to care. Liss DT; Baker DW Am J Prev Med; 2014 Mar; 46(3):228-36. PubMed ID: 24512861 [TBL] [Abstract][Full Text] [Related]
34. Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups. Chu KC; Anderson WF; Fritz A; Ries LA; Brawley OW Cancer; 2001 Jul; 92(1):37-45. PubMed ID: 11443607 [TBL] [Abstract][Full Text] [Related]
35. Hormone receptor and HER2 status in patients with breast cancer by races in southeastern Turkey. Kuzhan A; Adli M; Eryigit Alkis H; Caglayan D J BUON; 2013; 18(3):619-22. PubMed ID: 24065473 [TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of marital status in breast cancer survival: A population-based study. Martínez ME; Unkart JT; Tao L; Kroenke CH; Schwab R; Komenaka I; Gomez SL PLoS One; 2017; 12(5):e0175515. PubMed ID: 28475579 [TBL] [Abstract][Full Text] [Related]
37. Association between mammographic density and tumor marker-defined breast cancer subtypes: a case-control study. Shin J; Lee JE; Ko HY; Nguyen TL; Nam SJ; Hopper JL; Song YM Eur J Cancer Prev; 2018 May; 27(3):239-247. PubMed ID: 28957821 [TBL] [Abstract][Full Text] [Related]
38. Socioeconomic factors and breast carcinoma in multicultural women. Baquet CR; Commiskey P Cancer; 2000 Mar; 88(5 Suppl):1256-64. PubMed ID: 10705364 [TBL] [Abstract][Full Text] [Related]
39. Breast Cancer Subtype as a Predictor of Lymph Node Metastasis according to the SEER Registry. Mattes MD; Bhatia JK; Metzger D; Ashamalla H; Katsoulakis E J Breast Cancer; 2015 Jun; 18(2):143-8. PubMed ID: 26155290 [TBL] [Abstract][Full Text] [Related]
40. Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status. Tannenbaum SL; Koru-Sengul T; Zhao W; Miao F; Byrne MM Cancer J; 2014; 20(4):237-45. PubMed ID: 25098282 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]